·        Professor, School of Life Science, Tsinghua University

·        Prof. Yu’s laboratory first discovered and named migrasomes in 2014

·        Selected Awards

̶   Chinese Association of Cell Biology Outstanding Achievement Award(2021)

̶   Chang Jiang Scholars Award(2016)

̶   Ministry of Science and Technology Youth Science and Technology Innovation Leader     Talent(2016)

̶   Tan Jiazhen Life Science Innovation Award(2013)

̶   National Science Fund for Distinguished Young Scholars(2011)

• BS from Sichuan University

• 20+ years of experience in commercialization and public company operation

• Forms cofounder of Syntron Information (HK) Ltd, which is listed   on the Shenzhen Stock Exchange in 2015 (Stock Code: 300468)

• B.S. in Biological science from Tsinghua University, PhD on Oncology in Oncology from Memorial Sloan Kettering Cancer Center, specializing in pharmaceutical and healthcare industry strategies

• Proven track record in strategic financing and investment, with a deep understanding of the healthcare sector's complexities and opportunities

• Former Principal at Superstring Capital and healthcare consultant at McKinsey & Company, demonstrating expertise in healthcare management and investment

• B.S. in Biological Sciences, Shandong University; Ph.D. in Biomedical Sciences, National Institute of Biological Sciences (NIBS), Beijing / Peking University

• Extensive experience in biopharmaceutical research and development, leading programs in target validation and translational research

• Former Principal Scientist at BeiGene, with a strong focus on drug discovery and translational medicine